Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Auditor change
Director departure
Quarterly results
Appointed director
CC transcript

ALLOS THERAPEUTICS INC (ALTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/05/2012 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Eq...
Docs: "Amended and Restated Certificate of Incorporation of Allos Therapeutics, Inc",
"Amended and Restated Bylaws of Allos Therapeutics, Inc"
06/27/2012 8-K Quarterly results
04/20/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN ® in Europe"
04/06/2012 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger, by and among Allos Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Sapphire Acquisition Sub, Inc",
"Form of Contingent Value Rights Agreement",
"Form of Tender and Voting Agreement, by and between Spectrum Pharmaceuticals, Inc., Sapphire Acquisition Sub, Inc. and the stockholders as set forth therein",
"Amendment, to the Rights Agreement, by and between Allos Therapeutics, Inc. and Computershare Shareowner Services LLC (f/k/a Mellon Investor Services LLC), as amended"
03/19/2012 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
03/06/2012 8-K Quarterly results
Docs: "Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results"
03/05/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Compensation and Equity Awards",
"Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement for Section 16 Participants"
02/24/2012 8-K Appointed a new director
Docs: "Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement for Non-Employee Directors"
01/31/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency"
01/20/2012 8-K Form 8-K - Current report
01/10/2012 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "ALLOS THERAPEUTICS REPORTS 2011 FINANCIAL HIGHLIGHTS AND KEY BUSINESS PRIORITIES"
12/23/2011 8-K Resignation/termination of a director, Appointed a new director
Docs: "Amended and Restated Employment Agreement between Allos Therapeutics, Inc. and Bruce A. Goldsmith"
12/08/2011 8-K Form 8-K - Current report
11/03/2011 8-K Form 8-K - Current report
10/24/2011 8-K Termination of a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Other Events, Financial ...
Docs: "Allos Therapeutics Announces Termination of Merger Agreement with AMAG Pharmaceuticals"
10/11/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG Pharmaceuticals"
09/21/2011 8-K Other Events
08/19/2011 8-K Form 8-K - Current report
08/09/2011 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 1 to Agreement and Plan of Merger and Reorganization, by and among Allos Therapeutics, Inc., AMAG Pharmaceuticals, Inc. and Alamo Acquisition Sub, Inc"
07/20/2011 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "AMAG PHARMACEUTICALS AND ALLOS THERAPEUTICS AGREE TO MERGE TO STRENGTHEN COMMERCIAL PORTFOLIO AND ACHIEVE COST SYNERGIES"
06/23/2011 8-K Form 8-K - Current report
05/10/2011 8-K Quarterly results
Docs: "Allos Therapeutics Reports First Quarter 2011 Financial Results",
"Allos Therapeutics and Mundipharma Announce Strategic Collaboration for FOLOTYN"
03/04/2011 8-K Form 8-K - Current report
03/03/2011 8-K Quarterly results
Docs: "Allos Therapeutics Reports Fourth Quarter and Full Year 2010 Financial Results"
01/11/2011 8-K Form 8-K - Current report
12/21/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Allos Therapeutics' Marketing Authorisation Application for FOLOTYN® Accepted for Review by European Medicines Agency"
11/04/2010 8-K Quarterly results
Docs: "Allos Therapeutics Reports Third Quarter 2010 Financial Results"
10/22/2010 8-K Form 8-K - Current report
10/12/2010 8-K Form 8-K - Current report
09/17/2010 8-K Form 8-K - Current report
09/02/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/25/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/28/2010 8-K Form 8-K - Current report
07/28/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Allos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy